Today: 21 May 2026
NIO stock steadies in premarket after Europe pledge as EU lays out tariff workaround
13 January 2026
2 mins read

NIO stock steadies in premarket after Europe pledge as EU lays out tariff workaround

New York, Jan 13, 2026, 04:34 EST — Premarket

  • Nio announced plans to continue expanding its business in Europe after the EU outlined conditions allowing tariff swaps for minimum-price commitments
  • After jumping 4.5% on Monday, shares slipped roughly 0.2% in early premarket action
  • Traders are eyeing follow-up moves from Brussels and Beijing, with U.S. CPI data set for release Tuesday.

Nio Inc shares slipped slightly in early premarket Tuesday after the Chinese EV maker vowed to push forward with its European operations. This comes as Brussels proposed a potential path for China-made electric vehicles to sidestep EU tariffs. The U.S.-listed ADR dipped about 0.2% to $4.84, following a 4.5% gain on Monday when it closed at $4.85.

The European policy shift matters for Nio because access to Europe has become a question of pricing and margins, not just sales. A clearer route to ship cars without extra duties could alter how investors weigh risks tied to volumes, discounts, and Nio’s overseas strategy.

This week has seen high-beta China ADRs swing on policy news, only to reverse course after macro data hits. Nio’s stock, in particular, has been reacting as much to Brussels headlines as to developments out of Shanghai.

On Monday, the European Commission released guidance on “price undertaking” offers linked to anti-subsidy duties on battery electric vehicles imported from China. A price undertaking means committing to sell above a set minimum import price rather than paying tariffs. The Commission said it will evaluate these offers using the same legal standards and WTO rules, focusing on sales channels and the practice of “cross-compensation,” where profits might be shifted between products to obscure low EV prices. Trade and Economic Security

Reuters reported the Commission is sticking to a strict approach: minimum prices must be set for each EV model and configuration. The EU wants to curb cross-compensation risks, which it views as more significant when exporters also sell other types, like hybrids. The guidance mentioned that EU officials will factor in Chinese EV investments within the bloc. It also revealed the Commission has begun reviewing a minimum-price and import-quota proposal tied to a Volkswagen electric SUV built in China.

European Commission spokesperson Olof Gill said the market welcomes EVs “provided” they compete on a “level playing field.” Brussels is ready to consider price undertakings “in a serious way” if the right conditions arise. Rico Luman, senior economist at ING, noted minimum prices might offer Chinese brands “some comfort” to sustain exports over the long haul. Meanwhile, Stephen Chan, associate director at S&P Global Ratings, cautioned that demand could take a hit if the floor price narrows the gap with European competitors, AP reported. AP News

For Nio, the focus isn’t just a single tariff update but the bigger picture: whether exporters can file undertakings that Brussels will approve—and how quickly. That approach will likely extend to other China-connected EV makers selling in Europe, like bigger players BYD and Geely, both already on the EU’s radar.

But the downside risk remains. A high minimum price could erode the low-cost advantage that helped Chinese EVs gain market share. Meanwhile, prolonged talks or rejected proposals would maintain tariffs, reigniting the stop-start trade uncertainty that has rattled sentiment.

Investors are set to eye Tuesday’s U.S. consumer price index report for December 2025, due out at 8:30 a.m. ET. This data point is crucial for gauging rate expectations and frequently stirs premarket action in growth stocks just before the opening bell.

Stock Market Today

  • Scotiabank Shares Showing 32% Undervaluation at C$108 Amid Strong Returns
    May 20, 2026, 10:05 PM EDT. Scotiabank (TSX:BNS) stock has rallied to around C$108.50, delivering a 59.4% return over the past year and nearly 79% over five years highlighting strong performance. Despite this, valuation models suggest substantial remaining upside. Simply Wall St's Excess Returns analysis estimates the bank's intrinsic value at approximately C$160 per share, indicating it is 32.2% undervalued compared to current prices. This model calculates excess returns by comparing the bank's return on equity to its cost of equity, reflecting efficient shareholder profit generation. Investors are closely watching key fundamentals including balance sheet resilience and dividend yield as Scotiabank navigates evolving interest rate environments. The stock's valuation score of 4 out of 6 suggests moderate confidence among analysts that price gains can continue.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread
Previous Story

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread

Alibaba stock price today: BABA in focus after 10% jump on China “AI+ Manufacturing” push
Next Story

Alibaba stock price today: BABA in focus after 10% jump on China “AI+ Manufacturing” push

Go toTop